AU2002214286A1 - Method of profiling protein - Google Patents

Method of profiling protein

Info

Publication number
AU2002214286A1
AU2002214286A1 AU2002214286A AU1428602A AU2002214286A1 AU 2002214286 A1 AU2002214286 A1 AU 2002214286A1 AU 2002214286 A AU2002214286 A AU 2002214286A AU 1428602 A AU1428602 A AU 1428602A AU 2002214286 A1 AU2002214286 A1 AU 2002214286A1
Authority
AU
Australia
Prior art keywords
profiling protein
profiling
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002214286A
Inventor
Akiko Itai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002214286A1 publication Critical patent/AU2002214286A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
AU2002214286A 2000-11-15 2001-11-14 Method of profiling protein Abandoned AU2002214286A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000348054 2000-11-15
JP2000-348054 2000-11-15
JP2000-396950 2000-12-27
JP2000396950 2000-12-27
PCT/JP2001/009940 WO2002040990A1 (en) 2000-11-15 2001-11-14 Method of profiling protein

Publications (1)

Publication Number Publication Date
AU2002214286A1 true AU2002214286A1 (en) 2002-05-27

Family

ID=26604002

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002214286A Abandoned AU2002214286A1 (en) 2000-11-15 2001-11-14 Method of profiling protein

Country Status (6)

Country Link
US (1) US20040054144A1 (en)
EP (1) EP1343006A4 (en)
JP (1) JPWO2002040990A1 (en)
AU (1) AU2002214286A1 (en)
CA (1) CA2431655A1 (en)
WO (1) WO2002040990A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365852T3 (en) * 2003-11-07 2011-10-11 Novartis Ag USE OF FIBROBLAST GROWTH FACTOR FRAGMENTS.
US9202184B2 (en) * 2006-09-07 2015-12-01 International Business Machines Corporation Optimizing the selection, verification, and deployment of expert resources in a time of chaos
US8145582B2 (en) * 2006-10-03 2012-03-27 International Business Machines Corporation Synthetic events for real time patient analysis
US8055603B2 (en) * 2006-10-03 2011-11-08 International Business Machines Corporation Automatic generation of new rules for processing synthetic events using computer-based learning processes
US20080294459A1 (en) * 2006-10-03 2008-11-27 International Business Machines Corporation Health Care Derivatives as a Result of Real Time Patient Analytics
US7792774B2 (en) 2007-02-26 2010-09-07 International Business Machines Corporation System and method for deriving a hierarchical event based database optimized for analysis of chaotic events
US7917478B2 (en) * 2007-02-26 2011-03-29 International Business Machines Corporation System and method for quality control in healthcare settings to continuously monitor outcomes and undesirable outcomes such as infections, re-operations, excess mortality, and readmissions
US7788203B2 (en) * 2007-02-26 2010-08-31 International Business Machines Corporation System and method of accident investigation for complex situations involving numerous known and unknown factors along with their probabilistic weightings
US7970759B2 (en) * 2007-02-26 2011-06-28 International Business Machines Corporation System and method for deriving a hierarchical event based database optimized for pharmaceutical analysis
US7853611B2 (en) * 2007-02-26 2010-12-14 International Business Machines Corporation System and method for deriving a hierarchical event based database having action triggers based on inferred probabilities
US7930262B2 (en) * 2007-10-18 2011-04-19 International Business Machines Corporation System and method for the longitudinal analysis of education outcomes using cohort life cycles, cluster analytics-based cohort analysis, and probabilistic data schemas
US7779051B2 (en) * 2008-01-02 2010-08-17 International Business Machines Corporation System and method for optimizing federated and ETL'd databases with considerations of specialized data structures within an environment having multidimensional constraints
US10318877B2 (en) 2010-10-19 2019-06-11 International Business Machines Corporation Cohort-based prediction of a future event
US11359017B2 (en) 2016-07-01 2022-06-14 Tohoku University Method of altering an antibody-related adverse event based on SCD163 and/or CXCL5 levels
CN109712678B (en) * 2018-12-12 2020-03-06 中国人民解放军军事科学院军事医学研究院 Relationship prediction method and device and electronic equipment

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752583A (en) * 1984-11-29 1988-06-21 The United States Of America As Represented By The United States Department Of Energy Monoclonal antibodies to human hemoglobin S and cell lines for the production thereof
US5688655A (en) * 1988-02-10 1997-11-18 Ict Pharmaceuticals, Inc. Method of screening for protein inhibitors and activators
US5650276A (en) * 1991-03-11 1997-07-22 Creative Biomolecules, Inc. Morphogenic protein screening method
US5427922A (en) * 1992-04-07 1995-06-27 Takeda Chemical Industries, Ltd. DNA encoding a new angiotensin II type 1 receptor subtype and its expression
US5525490A (en) * 1994-03-29 1996-06-11 Onyx Pharmaceuticals, Inc. Reverse two-hybrid method
EP0790567A1 (en) * 1994-10-31 1997-08-20 ITAI, Akiko Method of retrieving novel ligand compounds from three-dimensional structure database
EP0833941B1 (en) * 1995-04-07 2008-10-22 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
CN1209111A (en) * 1995-12-28 1999-02-24 板井昭子 Prepn. method of physiologically active compound
US6566089B1 (en) * 1996-09-04 2003-05-20 Tularik Inc. Cell-based drug screens for regulators of gene expression
US5780258A (en) * 1996-09-04 1998-07-14 Tularik, Inc Drug screens for regulators of the expression of the obese gene
JPH10287696A (en) * 1997-04-11 1998-10-27 Iyaku Bunshi Sekkei Kenkyusho:Kk Estimation of function of protein
WO1999001409A1 (en) * 1997-07-03 1999-01-14 Akiko Itai Method for inferring protein functions with the use of ligand data base
SE9704836D0 (en) * 1997-12-22 1997-12-22 Astra Pharma Inc Novel receptor
CA2219958A1 (en) * 1998-01-07 1999-07-07 Ekkehard Leberer The g-protein .beta.subunit interaction domain of ste20p/pak family of protein kinases and uses thereof in bioassays
US6472151B1 (en) * 1998-08-19 2002-10-29 Bristol-Myers Squibb Company Method of screening for compounds that modulate the activity of a molecular target
JP2000319203A (en) * 1999-05-14 2000-11-21 Iyaku Bunshi Sekkei Kenkyusho:Kk Formation of three dimensional structure of compound
CN101382971A (en) * 2000-09-12 2009-03-11 株式会社医药分子设计研究所 Method of generating molecule-function network

Also Published As

Publication number Publication date
JPWO2002040990A1 (en) 2004-03-25
CA2431655A1 (en) 2002-05-23
WO2002040990A1 (en) 2002-05-23
EP1343006A4 (en) 2007-06-06
US20040054144A1 (en) 2004-03-18
EP1343006A1 (en) 2003-09-10

Similar Documents

Publication Publication Date Title
AU2001231085A1 (en) Method of making protein arrays
AU2002316137A1 (en) Method of determining protein interaction inhibitors
AU2001232799A1 (en) Protein c derivatives
AU2001280201A1 (en) Methods of synthesizing cell-free protein
AU2001241075A1 (en) Method of anticipating interaction between proteins
AU4107501A (en) Method of anticipating interaction between proteins
AU2002214286A1 (en) Method of profiling protein
AU2001286983A1 (en) Method of treatment
AU2001293538A1 (en) Novel protein tyrosine phosphatase inhibitor
AU2001278739A1 (en) Method of modifying microorganism-origin transglutaminase
GB2366639B (en) Method of comparing parts
AU2002221740A1 (en) Method for analyzing proteins
AU2001295450A1 (en) Method of polypeptide renaturation
AU2001294258A1 (en) Method of purifying plavastatin
AU2001237530A1 (en) Method
AUPQ904100A0 (en) Method of encryption
AU2001241636A1 (en) Halotherapy method
AU2001262177A1 (en) Method of treatment
AU2002354363A1 (en) Method of activating protein
AU2001244863A1 (en) Apoptin-associating protein
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2000274825A1 (en) Cosmetic method
AU2000273752A1 (en) Cosmetic method
AU2001253560A1 (en) Methods of treatment
AU2001263445A1 (en) Methods for protein design